Molecular basis for sunitinib efficacy and future clinical development

S Faivre, G Demetri, W Sargent… - Nature reviews Drug …, 2007 - nature.com
Abstract Sunitinib malate (SU11248/Sutent; Pfizer) is a multitargeted tyrosine kinase
inhibitor that has potent anti-angiogenic and antitumour activities. Definitive efficacy has …
被引用次数：886 相关文章

Molecular basis for sunitinib efficacy and future clinical development.

S Faivre, G Demetri, W Sargent… - Nature reviews. Drug …, 2007 - europepmc.org
Sunitinib malate (SU11248/Sutent; Pfizer) is a multitargeted tyrosine kinase inhibitor that has
potent anti-angiogenic and antitumour activities. Definitive efficacy has been demonstrated …

Molecular basis for sunitinib efficacy and future clinical development

S Faivre, G Demetri, W Sargent… - Nature Reviews Drug …, 2007 - go.gale.com
Abstract Sunitinib malate (SU11248/Sutent; Pfizer) is a multitargeted tyrosine kinase
inhibitor that has potent anti-angiogenic and antitumour activities. Definitive efficacy has …

Molecular basis for sunitinib efficacy and future clinical development.

S Faivre, G Demetri, W Sargent… - Nature Reviews Drug …, 2007 - search.ebscohost.com
Abstract Sunitinib malate (SU11248/Sutent; Pfizer) is a multitargeted tyrosine kinase
inhibitor that has potent anti-angiogenic and antitumour activities. Definitive efficacy has …

[引用][C] Molecular basis for sunitinib efficacy and future clinical development

S FAIVRE - Nat Rev Drug Discov, 2007 - cir.nii.ac.jp

Molecular basis for sunitinib efficacy and future clinical development

S Faivre, G Demetri, W Sargent… - Nature reviews. Drug …, 2007 - pubmed.ncbi.nlm.nih.gov
Sunitinib malate (SU11248/Sutent; Pfizer) is a multitargeted tyrosine kinase inhibitor that has
potent anti-angiogenic and antitumour activities. Definitive efficacy has been demonstrated …
[PDF] academia.edu

[PDF][PDF] Molecular basis for sunitinib efficacy and future clinical development

S Faivre, G Demetri, W Sargent, E Raymond - 2007 - academia.edu
Sunitinib malate (SU11248/Sutent; Pfizer) is a multitargeted tyrosine kinase inhibitor that has
potent anti-angiogenic and antitumour activities. Definitive efficacy has been demonstrated …

[引用][C] Molecular basis for sunitinib efficacy and future clinical development

S FAIVRE - Nat Rev Drug Discov, 2007 - cir.nii.ac.jp

[引用][C] Molecular basis for sunitinib efficacy and future clinical development

S Faivre, G Demetri, W Sargent… - Nature Reviews. Drug …, 2007 - Nature Publishing Group